Advancements in Inorganic Chiral Nanomaterials for Anti‐Tumor Immunotherapy
Cancer Science · 2026-06 · 117 (6) · 1543-1553
DOI: 10.1111/cas.70373 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Science, online erschienen am 30.03.2026. Verfasst von Siyu Chen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China. Hauptthemen laut MEDLINE: Immunotherapy, Neoplasms, Nanostructures. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Sichuan Province Science and Technology Plan Project (Sichuan Provincial Natural Science Foundation Project), Yibin Science and Technology Program Project, the Sichuan Provincial Medical Youth Innovation Research Project.
Abstract (Originalsprache)
While the past decade has witnessed unprecedented technological advancements, cancer remains a major health threat, with conventional therapies often constrained by substantial limitations. Immunotherapy, which mobilizes the body's immune system, is hindered by off‐target effects, allergic reactions, and cytokine storms. To enhance the precision, safety, and efficacy of cancer treatments, nanomaterials—especially those with nanoscale chiral properties—are offering a new approach for modulating immune responses. The optical anisotropy factor (g‐factor) of these nanomaterials has demonstrated precise, monotonic control over immune responses in vivo and in vitro, revealing that nanoscale chiral structures can act as key switches for dendritic cell maturation and function. Inorganic nanomaterials (INMs) are gaining attention for tumor immunotherapy due to their stability, biocompatibility, and precise synthesis. Their versatile surface modification, excellent optical/electrical/magnetic properties, and reproducibility further enhance their utility. Inorganic chiral nanomaterials (ICNMs), leveraging atomically precise chiral structures, enable efficient drug loading and radiosensitization to trigger anti‐tumor immunity, overcoming immunosuppressive limitations. Representative ICNMs include chiral gold nanorods, cadmium selenide quantum dots, and cerium oxide nanosheets. Current research focuses on chiral structure control, surface engineering, and multifunctional integration. ICNMs enhance antitumor immunity through targeted immunomodulator delivery, induction of immunogenic cell death, direct immune‐cell regulation, and reshaping of the tumor immune microenvironment. Despite their promise, challenges remain in scalable production, long‐term biosafety, and chiral stability in complex biological settings. Looking forward, ICNMs are poised to enable precise, efficient, and low‐toxicity tumor immunotherapy, driving transformative advances in cancer care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology, Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China.
- School of Basic Medical Sciences, Southwest Medical University, Luzhou, Sichuan, China.
- Department of Orthopaedics and Traumatology, Gongxian Hospital of Traditional Chinese Medicine, Yibin, Sichuan, China.
- Department of Oncology, The Second People's Hospital of Yibin, Yibin, Sichuan, China.
ORCID-Profile: Fang Xie
Förderung
- Sichuan Province Science and Technology Plan Project (Sichuan Provincial Natural Science Foundation Project)
- Yibin Science and Technology Program Project
- the Sichuan Provincial Medical Youth Innovation Research Project
- 2025 Chengdu Medical College Institutional Undergraduate Education and Teaching Reform Project
- the 2021 hospital-level incubation Project of the Second People's Hospital of Yibin
- Luzhou Municipal People's Government-Southwest Medical University Science and Technology Section Strategic Cooperation Project
- School-level research projects of Southwest Medical University
- Hejiang People's Hospital Special Research Project
Zitieren
APA
Chen, S., Tang, Q., Chen, X., Liang, Y., Qiu, J., Liao, Y., Li, C., Yu, H., Xie, F., & Liu, Z. (2026). Advancements in Inorganic Chiral Nanomaterials for Anti‐Tumor Immunotherapy. Cancer Science, 117(6), 1543-1553. https://doi.org/10.1111/cas.70373
Vancouver
Chen S, Tang Q, Chen X, Liang Y, Qiu J, Liao Y, et al. Advancements in Inorganic Chiral Nanomaterials for Anti‐Tumor Immunotherapy. Cancer Science. 2026;117(6):1543-1553. doi:10.1111/cas.70373
BibTeX
@article{Chen2026,
author = {Chen, Siyu and Tang, Qian and Chen, Xiqian and Liang, Yinghao and Qiu, Jin and Liao, Yongmei and Li, Changqiang and Yu, Hongru and Xie, Fang and Liu, Zongjunlin},
title = {Advancements in Inorganic Chiral Nanomaterials for Anti‐Tumor Immunotherapy},
journal = {Cancer Science},
year = {2026},
volume = {117},
number = {6},
pages = {1543--1553},
doi = {10.1111/cas.70373}
}
EUVIMED